Neurological consequences of psychotropic drug withdrawal in schizophrenic children.
D000293:Adolescent; D000328:Adult; D001259:Ataxia / Q000209:etiology; D001480:Basal Ganglia Diseases / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009069:Movement Disorders / Q000209:etiology*; D012008:Recurrence; D012075:Remission, Spontaneous; D012559:Schizophrenia / Q000188:drug therapy; D012561:Schizophrenia, Childhood / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome; D013881:Thioridazine / Q000627:therapeutic use; D013888:Thiothixene / Q000627:therapeutic use; D014149:Tranquilizing Agents
D014149:Tranquilizing Agents; D013888:Thiothixene; D006220:Haloperidol; D013881:Thioridazine; D005476:Fluphenazine